BrainsWay Sets November 25, 2026 Annual Shareholder Meeting With Auditor, Board and Equity Votes
Brainsway ( (BWAY) ) has issued an update.
On October 21, 2026, BrainsWay filed a Form 6-K announcing its annual general meeting of shareholders to be held at its Jerusalem headquarters on November 25, 2026. Shareholders of record as of October 26, 2026, including ordinary share and ADS holders, are invited to vote in person, by proxy, or electronically, subject to local regulatory requirements.
Key items on the agenda include appointing Kost Forer Gabbay & Kasierer of Ernst & Young Global as independent auditors for 2026, re-electing the current slate of directors, and approving equity grants in the form of restricted share units for CEO Hadar Levy and board members. The meeting will also provide a forum to discuss the company’s 2025 financial statements, underscoring ongoing governance, executive and director incentive alignment, and regulatory compliance for investors across its dual listings.
The most recent analyst rating on (BWAY) stock is a Buy
with a $19.00 price target.
To see the full list of analyst forecasts on Brainsway stock,
see the BWAY Stock Forecast page.
Spark’s Take on BWAY Stock
According to Spark, TipRanks’ AI Analyst, BWAY is a Outperform.
The score is driven primarily by improved profitability and a conservative balance sheet, reinforced by a broadly positive earnings call with raised guidance and strong Q2 growth/margin performance. Offsetting factors are cash-flow volatility and a stretched valuation (high P/E), while technicals are supportive but not a major incremental catalyst.
To see Spark’s full report on BWAY stock,
click here.
More about Brainsway
BrainsWay Ltd. is an Israel-based medical technology company focused on advanced non-invasive neurostimulation treatments, particularly Deep Transcranial Magnetic Stimulation (Deep TMS) systems for psychiatric and neurological disorders. The company markets its solutions globally, with listings in both the U.S. and Tel Aviv markets, targeting hospitals, clinics, and mental health providers.
Average Trading Volume: 118,452
Technical Sentiment Signal: Hold
Current Market Cap: $484.6M
See more data about BWAY stock on TipRanks’ Stock Analysis page.
